# Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

> **NCT04996719** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Rapamune

## Key facts

- **NCT ID:** NCT04996719
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-24
- **Primary completion:** 2023-08-25
- **Final completion:** 2023-08-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04996719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04996719, "Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04996719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*